Lpl Financial LLC Denali Therapeutics Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$15.83 - $23.35 $539,565 - $795,884	34,085 New	34,085 $699,000
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $158,335 - $255,499	-3,266 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $164,279 - $256,185	3,266 New	3,266 $256,000
Q1 2021 May 14, 2021	SELL	$53.8 - $81.53 $189,322 - $286,904	-3,519 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $129,815 - $329,237	3,519 New	3,519 $295,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.77B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.